●Call for Papers: Volume 16, Issue 2 — Submit by March-April 2026●Open Access — All articles freely available worldwide●Call for Papers: Volume 16, Issue 2 — Submit by March-April 2026●Open Access — All articles freely available worldwide
Journal Official Logo
International Journal ofAyurvedic and Herbal Medicine
arrow_backBack to Issue
arrow_backPrevious Article

An Ayurveda Approach for the Management of Fibromyalgia (A Literary Review)

Published:12 Jul 2013
visibility0 Viewsdownload0 Downloads
Sharma Chakrapany1*, Singh Chandan2, Purvia Rajendra3

1 Professor and HoD, Department of Dravyaguna Vigyan, Dr S R Rajasthan Ayurveda University, Jodhpur, India.

2 Associate Professor, Department of Dravyaguna Vigyan, Dr S R Rajasthan Ayurveda University, Jodhpur, India.

3 Assistant Professor, Department of Dravyaguna Vigyan, Dr S R Rajasthan Ayurveda University, Jodhpur, India

Corresponding Author:Sharma Chakrapany

picture_as_pdfDownload link10.47191/ijahm/v3i4.01

subjectAbstract

Fibromyalgia is estimated to affect 2-4% of the population, with a female to male incidence ratio of approximately 9:1. Three percent (3%) of the Indian population suffers from fibromyalgia, only 0.5% are aware of the conditions and the number of doctors who specialize in this in India are less than the numbers one can count on fingers”. Fibromyalgia is an anomaly. It is a condition still not fully understood and in some instances not accepted by mainstream medicine, although The American College of Rheumatology recognizes and defines it as a disease. Fibromyalgia is frequently co-morbid with psychiatric conditions such as depression and anxiety and stress-related disorders such as posttraumatic stress disorder. Fibromyalgia, a central nervous system disorder, is described as a "central sensitization syndrome" caused by neurobiological abnormalities which act to produce physiological pain and cognitive impairments as well as neuro-psychological symptomatology. Certain antidepressants such as amitriptyline and duloxetine have been found to be effective treatments as has the anticonvulsant drug pregabalin. Exercise improves fitness and sleep and may reduce pain and fatigue in some people with fibromyalgia. There is no permanent cure for FM; therefore, adequate symptom control should be goal of treatment. This paper / article reveals the some studies have been performed evaluating the role of herbs or herbal medicine for efficacy on fibromyalgia (FM). Massage therapy have the best evidence for effectiveness with FM. Massage is one of the oldest healing therapy. The massage is a part-n-parcel of the Panchakarma therapy in Ayurveda, which is gaining popularity for the rejuvenation purpose and for the treatment of arthritic disorders, neurological disorders and life style disorders. Using the basic principles and remedies from Ayurveda, may find out the solution for this syndrome. Herbals have a higher rank for the treatment of FMS. Many FMS patients seek relief from herbal remedies for symptomatic problems. Ayurveda approach is well and good, but ultimate relief should be found in combinations of herbals along with other adjunctive recommendations. Panchakarma, Massage therapy, Marma therapy of Ayurveda also can play a vital role in this concern. Present paper is an attempt with in-depth literary review to explore the possible use of Ayurveda for the management of the Fibromyalgia.

sellKeywords

AyurvedaFMPanchakarmaMarmaVataMans Dhatu

format_list_numberedReferences

  1. James Braly, MD; Derrick M. DeSilva, Jr., MD; John Hess, FBIH, Natural Choices, The Natural Choices/Informed Decisions – Fibromyalgia, A Publication Health Trust Alliance, Inc., 501 CrownPointe Way, Suite 120, Lawrenceville, Georgia 30045, (2000), p-1
  2. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160e72.
  3. http://healthmeup.com/news-buzz/survivors-story-in-conversation-with-sagarika-chakraborty-fibromyalgia-survivor/14352, retrieved on 2013.7.14
  4. (a) "Q&A Fibromyalgia". Niams.nih.gov. Retrieved 2013-07-15. (b)http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/fibromyalgia.pdf#search=%22fibromyalgia%22, retrieved on 30th July 2013
  5. Ngian GS, Guymer EK, Littlejohn GO (February 2011). "The use of opioids in fibromyalgia" (PDF). Int J Rheum Dis 14 (1): 6–11. doi:10.1111/j.1756-185X.2010.01567.x. PMID 21303476.
  6. (a) Häuser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M, Henningsen P (June 2009). "Fibromyalgia syndrome: classification, diagnosis, and treatment". Dtsch Arztebl Int 106 (23): 383–91. doi:10.3238/arztebl.2009.0383. PMC 2712241. PMID 19623319. (b) Clauw, DJ.; Arnold, LM.; McCarberg, BH.; For The, Fibrocollaborative (Sep 2011). "The science of fibromyalgia". Mayo Clin Proc 86 (9): 907–11. doi:10.4065/mcp.2011.0206. PMC 3258006. PMID 21878603.
  7. (a) http://www.hsc.missouri.edu/~fibro/fm-pt.html, retrieved on 31st July 2013 (b) http://www.healthtouch.com, retrieved on 31st July 2013
  8. Goldberg, Burton; et.al. Chronic Fatigue, Fibromyalgia and Environmental Illness. Future Medical Publishing, Inc. 1998.
  9. Ngian GS, Guymer EK, Littlejohn GO (February 2011). "The use of opioids in fibromyalgia" (PDF). Int J Rheum Dis 14 (1): 6–11. doi:10.1111/j.1756-185X.2010.01567.x. PMID 21303476.
  10. (a) James Braly, MD; Derrick M. DeSilva, Jr., MD; John Hess, FBIH, Natural Choices, The Natural Choices/Informed Decisions – Fibromyalgia, A Publication Health Trust Alliance, Inc., 501 Crown Pointe Way, Suite 120, Lawrenceville, Georgia 30045, (2000), p-1 (b) Maletic, V.; Raison, CL. (2009). "Neurobiology of depression, fibromyalgia and neuropathic pain". Front Biosci 14: 5291-338. doi:10.2741/3598. PMID 19482616.
  11. Sommer, C.; Häuser, W.; Burgmer, M.; Engelhardt, R.; Gerhold, K.; Petzke, F.; Schmidt-Wilcke, T.; Späth, M. et al. (Jun 2012). "[Etiology and pathophysiology of fibromyalgia syndrome]". Schmerz 26 (3): 259–67. doi:10.1007/s00482-012-1174-0. PMID 22760458. (d) Geoffroy PA, Amad A, Gangloff C, Thomas P. (May 2012). "Fibromyalgia and psychiatry: 35 years later... what's new?". Presse Med. 41 (5): 555–65. doi:10.1016/j.lpm.2011.08.008.. PMID 21993145.
  12. Wolfe F (February 1989). "Fibromyalgia: the clinical syndrome". Rheum Dis Clin North Am 15 (1): 1–18. PMID 2644671.
  13. Wallace DJ, Hallegua DS. (October 2002). "Fibromyalgia: the gastrointestinal link". Curr Pain Headache Rep. 8 (5): 364–8. doi:10.1007/s11916-996-0009-z. PMID 15361320.
  14. Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. (January-February 1997). "The relationship between fibromyalgia and interstitial cystitis". J Psychiatr Res. 31 (1): 125–31. doi:10.1016/S0022-3956(96)00051-9. PMID 9201654.
  15. Simms RW, Goldenberg DL. (August 1988). "Symptoms mimicking neurologic disorders in fibromyalgia syndrome". J Rheumatol. 15 (8): 1271–3. PMID 3184073.
  16. Glass JM. (December 2006). "Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions". Curr Rheumatol Rep. 8 (6): 425–9. doi:10.1007/s11926-006-0036-0. PMID 17092441.
  17. (a) Buskila D, Cohen H. (October 2007). "Comorbidity of fibromyalgia and psychiatric disorders". Curr Pain Headache Rep. 11 (5): 333-8. doi:10.1007/s11916-007-0214-4. PMID 17894922. (b) Schweinhardt P, Sauro KM, Bushnell MC. (October 2008). "Fibromyalgia: a disorder of the brain?". Neuroscientist. 14 (5): 415-21. doi:10.1177/1073858407312521. PMID 18270311.
  18. Yunus MB. (December 1983). "Fibromyalgia syndrome: a need for uniform classification". J Rheumatol. 10 (6): 841-4. PMID 6582267.
  19. Buskila D, Cohen H. (October 2007). "Comorbidity of fibromyalgia and psychiatric disorders". Curr Pain Headache Rep. 11 (5): 333-8. doi:10.1007/s11916-007-0214-4. PMID 17894922.
  20. Bartels EM et al. (2009). "Fibromyalgia, diagnosis and prevalence. Are gender differences explainable?". Ugeskr Laeger. 171 (49): 3588–92. PMID 19954696.
  21. Schweinhardt P, Sauro KM, Bushnell MC. (October 2008). "Fibromyalgia: a disorder of the brain?". Neuroscientist. 14 (5): 415–21. doi:10.1177/1073858407312521. PMID 18270311.
  22. Buskila D, Sarzi-Puttini P (2006). "Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome". Arthritis Res Ther. 8 (5): 218. doi:10.1186/ar2005. PMC 1779444. PMID 16887010.
  23. http://www.hsc.missouri.edu/~fibro/fm-pt.html, retrieved on 31st July 2013
  24. Gowans SE, deHueck A (2004). "Effectiveness of exercise in management of fibromyalgia". Current opinion in rheumatology 16 (2): 138–42. doi:10.1097/00002281-200403000-00012. PMID 14770100.
  25. http://www.americanwholehealth.com
  26. http://www.coloradohealthnet.org
  27. (a) Häuser, W.; Wolfe, F.; Tölle, T.; Uçeyler, N.; Sommer, C. (Apr 2012). "The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis". CNS Drugs 26 (4): 297-307. doi:10.2165/11598970-000000000-00000. PMID 22452526. (b) Häuser W, Bernardy K, Uçeyler N, Sommer C (January 2009). "Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis". JAMA 301 (2): 198–209. doi:10.1001/jama.2008.944. PMID 19141768.
  28. (a) Busch A, Schachter CL, Peloso PM, Bombardier C (2002). "Exercise for treating fibromyalgia syndrome". In Busch, Angela. Cochrane database of systematic reviews (Online) (3): CD003786. doi:10.1002/14651858.CD003786. PMID 12137713. (b) Gowans SE, deHueck A (2004). "Effectiveness of exercise in management of fibromyalgia". Current opinion in rheumatology 16 (2): 138-42. doi:10.1097/00002281-200403000-00012. PMID 14770100.
  29. (a) Carette S, McCain GA, Bell DA, Gan AG. “Evaluation of amitriptyline in primary fibrositis.” Arth Rheum 1986 May; 29(5): 655-659. (b) Carette S, et.al. “Comparison of amitriptyline, cyclobenzaprine and placebo in the treatment of fibromyalgia. Arth Rheum 1994 Jan; 37 (1): 32-48.
  30. Mense S. Neurobiological concepts of fibromyalgia: the possible role of descending spinal tracts. Scand J Rheumatol 2000; 113 (suppl): 24-29.
  31. (a) Neeck G, Pathogenic mechanisms of fibromyalgia. Ageing Res Rev 2002; 1: 243-55. (b) Crofford LJ. The hypothalamic-pituitary- adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol 1998; 57 (suppl 2):67-71.
  32. Russell IJ, Or MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593-601.
  33. Paiva ES, Deodhar A, Jones KD, Bennett R. Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 2002; 46: 1344-50.
  34. (a) Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an etiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rhematology 2001; 40: 743-749. (b) Gur A, Karakoc M, Nas K, Cevik R, Denli A, Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002; 29: 358-61 (c) Gur A, Karakoc M, Erdogan S, Nas K, Cevik R, Sarac AJ. Regional serebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002; 20: 753-60
  35. van West D, Maes M. Neuroendocrine and immune aspects of fibromyalgia. Bio Drugs 2001; 15: 521-31.
  36. Jeschonneck M, Grohmann G, Hein G, Sprott H. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology (Oxford) 2000; 39: 917-21.
  37. Bradley LA, Weigent DA, Sotolongo A. Blood serum levels of nitric oxide (NO) are elevated in women with fibromyalgia (FM): possible contributions to central and peripheral sensitization. Arthritis Rheum 2000; 43: 173.
  38. Hamaty D, Valentine JL, Howard R, Howard CW, Wakefield V, Patten MS. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5- month study. J Rheumatol 1989; 19(suppl): 164-68.
  39. Sprott H. What can rehabilitation interventions achieve in patients with primary fibromyalgia? Curr Opin Rheumatol 2003; 15: 145-50.
  40. Veintraub MI. Complementary and alternative methods of treatment of neck pain. Phys Med Rehabil Clin N Am 2003; 14: 659-74.
  41. http://www.charaka.org/fibromyalgia.html
  42. http://ayurveda-foryou.com/treat/fibromyalgia.html, retrieved on 31st July 2013.
  43. Ramsey SM. Holistic manual therapy techniques. Primary Care 1997; 24(4): 759-7786.
  44. (a) Harris RE, Clauw DJ. The use of complementary medical therapies in the management of myofascial pain disorders. Curr Pain Headache Rep 2002; 6: 370-374. (b) Pioro- Boisset M, Esdaile JM, Fitzchareles MA. Alternative Medicine use in fibromyalgia. Arthritis Care Res 1996; 9(1): 13-17
  45. Pioro- Boisset M, Esdaile JM, Fitzchareles MA. Alternative Medicine use in fibromyalgia. Arthritis Care Res 1996; 9(1): 13-17.
  46. Lars Bjørn Rasmussen, Knut Mikkelsen, Margaretha Haugen, Are H. Pripp, Jeremy Z. Fields, Øystein T. Førre, Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II-a 24-month follow-up pilot study, Clinical Rheumatology, May 2012, Volume 31, Issue 5, pp 821-827
  47. Brattberg G. Connective tissue massage in the treatment of fibromyalgia. Eur J Pain 1999; 3: 235-45.
  48. Buckelew SP, Huyser B, Hewett JE, Parker JC, Johnson JC, Conway R, et al. Self-efficacy predicting outcome among fibromyalgia subjects. Arthritis Care Res 1996; 9: 97-104.
  49. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp537-539
  50. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp488-490
  51. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 66-69
  52. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp763-765
  53. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 304-306
  54. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp331-333
  55. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 820-821
  56. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 822-823
  57. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 282-283
  58. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 632-634
  59. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 455-457
  60. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 221-223
  61. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp469-471
  62. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 225-227
  63. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 223-225
  64. Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 162-164 (Charaka Samhita, Sutra Section, Ch. 25).
  65. (a) Sharma P V, Dravyaguna Vigyan II, Chowkhambha Bharati Academy, Varanasi, India, 2006, pp 54-56 and (b) Shashikant Patwardhan, Ayurvedic Treatment of Fibromyalgia (CFS), http://www.boloji.com/index.cfm?md=Content&sd=Articles&ArticleID=1186
  66. Subhash Ranade, Anil lele, Ayurveda and Marma Therapy, online available book on – http://www.scribd.com/doc/130583178/Ayurveda-Marma-Therapy-pdf
  67. Frawley, David. Ayurvedic Healing: A Comprehensive Guide. Delhi: Motilal Banarsidass Publishers, 1989.
  68. Frawley, David. Ayurveda and Marma Therapy: Energy Points in Yogic Healing. Twin Lakes: Lotus Press, 2003.

How to Cite

Chakrapany, S., Chandan, S., & Rajendra, P. (2013). An Ayurveda Approach for the Management of Fibromyalgia (A Literary Review). International Journal of Ayurvedic and Herbal Medicine, 3(4). https://doi.org/10.47191/ijahm/v3i4.01

APA

American Psychological Association Style

arrow_back
Previous ArticleStress Relaxation Through Ayurveda